Current affiliation: Envision Pharma GroupSubject: Medicine And Medical SciencesPrimary location: United Kingdom
Published in:Patient Related Outcome MeasuresPublication date:2016-06-01
A new patient-reported outcome (PRO) instrument has been developed to assess the severity of irritable bowel syndrome in patients with diarrhea (IB...
Published in:Postgraduate MedicinePublication date:2017-04-20
Published in:Patient Related Outcome MeasuresPublication date:2017-07-01
Published in:Therapeutic Advances in GastroenterologyPublication date:2017-08-24